Publications in other proceedings
-
SBBf-2025
FROM HIGH-THROUGHPUT SCREENING TO CELLULAR VALIDATION: DEVELOPMENT OF A NOVEL IDO1 INHIBITOR TARGETING NEUROPATHIC PAIN.
-
SBBf 2023
Investigating Small Molecule Modulators of PKM2 Tetramerization
-
SBBf 2023
TARGETING INDOLEAMINE-2,3-DIOXYGENASE 1 (IDO1) FOR NEUROPATHIC PAIN DRUG DEVELOPMENT – SCREENING, ORTHOGONAL ASSAY AND CHARACTERIZATION OF NOVEL INHIBITORS.
Streamline your Scholarly Event
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
